Given the importance of persistent inflammation and immune activation in the pathogenesis of post-COVID lung damage, we evaluated whether levels of anti-SARS-CoV-2 IgG and the pro-inflammatory chemokines CXCL9 and CXCL10 were associated with pulmonary sequelae at four months post-infection. This evidence concerns the gene CXCL9 and infection.